Inovio Pharmaceuticals Ad Alert Inovio Pharmaceuticals Claims about the development of a coronavirus vaccine are at the center of a class-action lawsuit.
Hi-Tech Pharmaceuticals Garcinia Cambogia Extract Class Action Hi-Tech Pharmaceuticals Garcinia Cambogia Extract
Pharmaceuticals Top the Spam List Consumer News Pharmaceuticals Top the Spam List Spam levels have dropped to a 3-year record low, reports security firm, Symantec, in their November 2011 Intelligence Report. But before you start jumping up and down with excitement, keep…
Amberen Brands Amberen TINA.org investigated the marketing for Amberen, a menopause supplement brand owned and marketed by Alliance Pharmaceuticals, and found that it is deceptively promoted as “clinically proven” to provide menopause and…
A Growing List of Coronavirus Scams Consumer News A Growing List of Coronavirus Scams A master list of known and alleged scams.
Study Calls on FDA to Act on Stimulant Found in Weight-Loss Products Consumer News Study Calls on FDA to Act on Stimulant Found in Weight-Loss Products Amphetamine-like ingredient found in Acacia rigidula dietary supplements could trigger harmful reactions.
Proactiv Class Action Proactiv Allegations: Misleadingly representing that products were safe when they contained, or were at risk of containing, the carcinogen benzene
The Menopause Deception Epidemic Consumer News The Menopause Deception Epidemic How the supplement industry is taking advantage of women and what TINA.org is doing to fight it.
FDA Warns Companies about Dangers of Stimulants in Supplements Consumer News FDA Warns Companies about Dangers of Stimulants in Supplements Eight products found to have BMPEA and 17 products contain DMBA, both amphetamine-like stimulants.
Menopause Supplements Industries Menopause Supplements TINA.org investigated marketing tactics used by the menopause supplement industry and urged 100 companies to review their marketing.
Is Deceptive Drug Marketing Killing Us? Consumer News Is Deceptive Drug Marketing Killing Us? Complaint alleges that painkiller companies schemed to deceive U.S. market.